Egan JM - Search Results

1

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.

Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH. Perry T, et al. Among authors: egan jm. J Pharmacol Exp Ther. 2002 Sep;302(3):881-8. doi: 10.1124/jpet.102.037481. J Pharmacol Exp Ther. 2002. PMID: 12183643

2

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.

Wang Y, Perfetti R, Greig NH, Holloway HW, DeOre KA, Montrose-Rafizadeh C, Elahi D, Egan JM. Wang Y, et al. Among authors: egan jm. J Clin Invest. 1997 Jun 15;99(12):2883-9. doi: 10.1172/JCI119482. J Clin Invest. 1997. PMID: 9185511 Free PMC article.

3

Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness.

Montrose-Rafizadeh C, Wang Y, Janczewski AM, Henderson TE, Egan JM. Montrose-Rafizadeh C, et al. Among authors: egan jm. Mol Cell Endocrinol. 1997 Jun 20;130(1-2):109-17. doi: 10.1016/s0303-7207(97)00079-8. Mol Cell Endocrinol. 1997. PMID: 9220027

4

The effects of GLP-1 on insulin release in young and old rats in the fasting state and during an intravenous glucose tolerance test.

De Ore K, Greig NH, Holloway HW, Wang Y, Perfetti R, Egan JM. De Ore K, et al. Among authors: egan jm. J Gerontol A Biol Sci Med Sci. 1997 Sep;52(5):B245-9. doi: 10.1093/gerona/52a.5.b245. J Gerontol A Biol Sci Med Sci. 1997. PMID: 9310073

5

Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions.

Wang Y, Kole HK, Montrose-Rafizadeh C, Perfetti R, Bernier M, Egan JM. Wang Y, et al. Among authors: egan jm. J Mol Endocrinol. 1997 Dec;19(3):241-8. doi: 10.1677/jme.0.0190241. J Mol Endocrinol. 1997. PMID: 9460645

6

GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.

Yang H, Egan JM, Wang Y, Moyes CD, Roth J, Montrose MH, Montrose-Rafizadeh C. Yang H, et al. Among authors: egan jm. Am J Physiol. 1998 Sep;275(3):C675-83. doi: 10.1152/ajpcell.1998.275.3.C675. Am J Physiol. 1998. PMID: 9730951

7

Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations.

Greig NH, Holloway HW, De Ore KA, Jani D, Wang Y, Zhou J, Garant MJ, Egan JM. Greig NH, et al. Among authors: egan jm. Diabetologia. 1999 Jan;42(1):45-50. doi: 10.1007/s001250051111. Diabetologia. 1999. PMID: 10027577

8

Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells.

Wang X, Cahill CM, Piñeyro MA, Zhou J, Doyle ME, Egan JM. Wang X, et al. Among authors: egan jm. Endocrinology. 1999 Oct;140(10):4904-7. doi: 10.1210/endo.140.10.7158. Endocrinology. 1999. PMID: 10499550

9

Glucagon-like peptide-1 does not mediate amylase release from AR42J cells.

Zhou J, Montrose-Rafizadeh C, Janczewski AM, Pineyro MA, Sollott SJ, Wang Y, Egan JM. Zhou J, et al. Among authors: egan jm. J Cell Physiol. 1999 Dec;181(3):470-8. doi: 10.1002/(SICI)1097-4652(199912)181:3<470::AID-JCP11>3.0.CO;2-P. J Cell Physiol. 1999. PMID: 10528233

10

Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells.

Zhou J, Wang X, Pineyro MA, Egan JM. Zhou J, et al. Among authors: egan jm. Diabetes. 1999 Dec;48(12):2358-66. doi: 10.2337/diabetes.48.12.2358. Diabetes. 1999. PMID: 10580424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters